Bioavailability of gentamicin in dogs after intramuscular or subcutaneous injections

Robert C. Wilson, Sue H. Duran, Charles R. Horton, Lyndon WrightAmerican 1989 · DOI

Abstract

SUMMARY Healthy adult mixed-breed dogs, assigned to 2 groups of 6 dogs each, were given 3 mg of gentamicin sulfate/kg of body weight on 3 injection days 7 days apart. Group 1 was given gentamicin by rapid iv injection, by injection into the belly of the longissimus muscle at the first lumbar vertebrae ( im site 1), and by injection in the belly of the biceps femoris muscle ( im site 2). Group 2 was given gentamicin by rapid iv injection, by sc injection into the space over the cranial angle of the scapula on the midline ( sc site 1), and by sc injection just caudal to the crest of the ilium ( sc site 2). Pharmacokinetic values (mean ± sd ) from 12 dogs given gentamicin iv were 54.4 ± 15.4 minutes for the effective half life, 2.29 ± 0.48 ml/kg/min for clearance, and 172 ± 25.4 ml/kg for volume of distribution at steady state. Bioavailability (93.92 to 96.65%) and peak plasma gentamicin concentration (9.43 to 10.89 μg/ml) were independent of injection site, but time to peak concentration when gentamicin was given at sc site 2 (43.33 minutes) was significantly ( P < 0.05) longer than that when gentamicin was given at im site 1 (27.50 minutes). Absorption half-life was shorter after injections were given at both im sites (8.9 and 9.8 minutes) than after injection was given at sc site 2 (18 minutes).
BibTeX
@inproceedings{wilson1989bioavailability,
  author = {Robert C. Wilson and Sue H. Duran and Charles R. Horton and Lyndon Wright},
  title = {{Bioavailability of gentamicin in dogs after intramuscular or subcutaneous injections}},
  booktitle = {American},
  year = {1989},
  doi = {10.2460/ajvr.1989.50.10.1748},
}

Loading related content...

Figure